Related Experiment Videos
Different structural requirements within the switch II region of the Ras protein for interactions with specific
S A Moodie1, M Paris, E Villafranca
1Dept. Mole. Biology, Bristol Myers & Squibb Research Institute, Princeton, New Jersey 08543, USA.
Abstract:
Ras proteins function through the formation of specific complexes with Raf-1, B-raf, PI-3 kinase and RalGDS. These interactions all require Ras-GTP with an intact effector binding domain (Switch I region). We have examined the requirements of the Switch II region (amino acids 60-72) for the production of stable interactions between Ras and its downstream effectors. A point mutation at position 65 or 64 combined with additional mutations at either position 65 or 71 rendered nucleotide-free Ras protein unable to stably interact with Ras specific guanine nucleotide exchange factors. Ha-Ras containing point mutations at positions 65 and 71 possessed a twofold higher affinity for B-raf and consequently MEK1. The point mutation at 64, in combination with additional point mutations at either position 65 or 71, resulted in a protein which failed to interact with either PI-3 kinase or neurofibromin, though these Ras mutants effectively bound both Raf-1 and B-raf. An activated form of Ras, Q61L-Ras, associated with all effector proteins independent of the bound guanine nucleotide. Q61L-Ras-GDP was almost as effective as wild type Ras-GMPPNP in the in vitro activation of MEK1 and MAP kinase. Competitive studies with the catalytic domain if neurofibromin, NF1-GRD, demonstrated that its interaction with Ras-GMPPNP is mutually exclusive with both Raf-1 and B-raf. These data suggest that rasGAP and neurofibromin are unable to downregulate Ras-GTP complexed to Raf-1 or B-raf.
Insights
Ras protein interactions with effectors like Raf-1 are modulated by the Switch II region. Mutations impact binding to guanine nucleotide exchange factors, PI-3 kinase, and neurofibromin, affecting signaling pathways.
Area of Science:
- Molecular Biology
- Cell Signaling
- Protein Interactions
Background:
- Ras proteins are key regulators of cellular signaling pathways.
- Ras-GTP forms specific complexes with downstream effectors, including Raf-1, B-raf, PI-3 kinase, and RalGDS.
- These interactions are crucial for signal transduction and are dependent on the Ras effector binding domain (Switch I region).
Purpose of the Study:
- To investigate the role of the Ras Switch II region (amino acids 60-72) in mediating stable interactions with downstream effector proteins.
- To determine how specific point mutations in the Switch II region affect Ras binding affinity and downstream signaling.
- To elucidate the competitive binding dynamics between Ras effectors and negative regulators like neurofibromin.
Main Methods:
- Site-directed mutagenesis was used to introduce point mutations into the Ras Switch II region.
- In vitro binding assays were performed to assess the affinity of wild-type and mutant Ras proteins for various effector proteins (Raf-1, B-raf, PI-3 kinase, RalGDS) and regulators (guanine nucleotide exchange factors, neurofibromin).
- Enzyme activity assays (MEK1, MAP kinase) were conducted to evaluate the functional consequences of altered Ras-effector interactions.
Main Results:
- Mutations at positions 65 or 64 in the Switch II region impaired the interaction of nucleotide-free Ras with guanine nucleotide exchange factors.
- Specific mutations (e.g., at positions 65 and 71) enhanced the affinity of Ras for B-raf and MEK1 activation.
- Other Switch II mutations (e.g., at position 64 with 65 or 71) disrupted binding to PI-3 kinase and neurofibromin while maintaining interaction with Raf-1 and B-raf.
- An activated Ras mutant (Q61L-Ras) bound all effectors irrespective of nucleotide-bound state, and Q61L-Ras-GDP effectively activated MEK1 and MAP kinase.
- Competitive binding studies revealed that neurofibromin's interaction with Ras is mutually exclusive with Raf-1 and B-raf binding.
Conclusions:
- The Switch II region of Ras proteins plays a critical role in determining effector specificity and interaction stability.
- Specific mutations in Switch II can selectively alter Ras binding to different downstream targets, impacting signaling outcomes.
- Ras-GTP complexed with Raf-1 or B-raf may be resistant to downregulation by rasGAP and neurofibromin, suggesting a mechanism for sustained signaling.
- These findings provide insights into the intricate regulation of Ras signaling pathways and their modulation by effector interactions.